Management

Scott Baker

SCOTT BAKER, PEng

SCOTT BAKER, PEng

Chief Executive Officer

Scott Baker is a serial entrepreneur with 20+ years of experience positioning startup companies for a sustainable competitive edge. Mr. Baker joined Tornado Spectral Systems at its inception and has spearheaded the commercialization of its flagship HyperFlux PRO Plus Raman analyser product. Prior to Tornado, Mr. Baker served in executive and senior management positions at high tech start-up companies that were successfully acquired or completed an IPO including Fresco Microchip, Silicon Optix, and Genesis Microchip. At Fresco, through a complex worldwide supply chain consisting of firms from Taiwan, China, Malaysia and the USA, he launched novel silicon tuner products and oversaw an unprecedented ramp of 30 million shipments in the first production year. Mr. Baker has a Bachelor of Technology degree in Electrical Engineering from Ryerson Polytechnical Institute and is a member of Professional Engineers Ontario.

Bradford Behr

BRADFORD BEHR, BA, PhD

BRADFORD BEHR, BA, PhD

Chief Technology Officer

Bradford Behr is a co-inventor of Tornado's proprietary HTVS technology and currently serves as Chief Technology Officer, guiding the company's technology development roadmap and identifying potential additions to the intellectual property portfolio. In his prior role as TSS Senior Optical Scientist he was responsible for optical engineering and system architecture for many of Tornado's prior and current spectroscopy products including the HyperFlux PRO Plus 785 and OCT-Prime. Dr. Behr received his BA in Astronomy from Williams College and his PhD in Astrophysics from the California Institute of Technology. He held postdoctoral research fellowships at The University of Texas McDonald Observatory and the U.S. Naval Observatory, pioneering new analysis methods and cutting-edge astronomical spectrometer designs for quantifying the chemical composition and dynamics of stars in our galaxy. Much of this work has translated directly to Tornado's advancement of the state-of-the-art for terrestrial spectroscopy applications such as real-time monitoring and industrial process analytics.

Aaron Weinroth

AARON WEINROTH, BASc, MASc, PEng

AARON WEINROTH, BASc, MASc, PEng

Chief Marketing Officer

Aaron Weinroth is responsible for many aspects of Tornado’s technology commercialization including marketing, product management, business development, and the company’s intellectual property portfolio. He previously served in senior business and engineering capacities in the medical device and imaging industries for both small early stage growth organizations (XLTEK, Traxtal Technologies) and the large global corporations (Natus Medical, Phillips Healthcare) that acquired them. Aaron earned Bachelor’s and Master’s degrees in Electrical and Biomedical Engineering from the University of Toronto and is a licensed professional engineer.

Mark S. Kemper

MARK S. KEMPER, B.S., M.S.

MARK S. KEMPER, B.S., M.S.

Director of Applications and Customer Service

Mark Kemper has accumulated over 20 years of experience, both industrial and academic, developing and deploying a diverse set of technologies including benchtop instruments, handheld devices and process equipment. Prior to this, he worked as an Analytical Chemist and Group Leader in the pharmaceutical industry for nearly 10 years and held various positions such as Applications Scientist, Applications Manager, Sales Director, and VP of Sales. As Director of Applications Development and Customer Service at Tornado Spectral Systems, Mark is primarily responsible for supporting global sales and enabling customer success. Throughout his career, Mark has been extensively involved with spectroscopic technologies including Raman, FT-IR, Near-IR, Terahertz and NMR. Mark has worked on both the business and technical side and published 25 peer-reviewed papers in reputed journals and presented at 100+ international conferences and also contributed to one book chapter. Mark received his B.S. in chemistry from the University of Dayton (USA) and his M.S. in biological chemistry from the University of Minnesota (USA). He is currently pursuing his PhD under the guidance of Professor Toshiro Fukami at Meiji Pharmaceutical University in Tokyo.